The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout

Chio Yokose, Natalie McCormick, Abhishek Abhishek, Nicola Dalbeth, Tristan Pascart, Frédéric Lioté, Angelo Gaffo, John FitzGerald, Robert Terkeltaub, Meghan E. Sise, James L. Januzzi, Deborah J. Wexler, Hyon K. Choi